Close Menu

eCase Study Videos

Displaying 1 - 3 of 3
March 20, 2020
Sponsored by
Thermo Fisher Scientific

Enhanced, Rapid Target Identification by NGS for Vaccine Development

Case Study

Next-generation sequencing (NGS) is the primary technology used to identify genomic targets for vaccine development. Enhanced options for NGS on Illumina systems now make it possible to identify multiple potentially pathogenic strains of a disease and understand the rate of evolution quickly, with improved precision. Two complementary sequencing methods are used to identify targets for vaccine development. Whole-genome sequencing using the Invitrogen Collibri DNA Library Prep Kits provide the entire genomic assembly, offering an improvement over older transposomic methods. Collibri 3ʹ mRNA Library Prep kits provide gene expression insights into pathogen, host and host-pathogen interactions that can be used to refine genomic targets for vaccine development.

Sponsored by
December 02, 2019
Sponsored by

Powering Precision Medicine at Apollo Genetics

Case Study

Apollo Genetics, located in Baton Rouge, Louisiana, performs next-generation sequencing (NGS) diagnostics for cancer and pharmacogenetics. The CLIA-certified, CAP-accredited lab performs this testing for reference labs, physicians and directly to individuals. In 2019, Apollo acquired MedCompGx, also a Louisiana-based provider of NGS testing for cancer and pharmacogenetics. Today, the combined organization continues to deliver high-quality technology-driven services.

Next-generation sequencing is complex and requires data-intensive analysis. Learn how Apollo Genetics is leveraging software from Sunquest – Sunquest Mitogen LIMS and Sunquest Mitogen Genetics – across the newly combined organization to scale for volume and complexity, while maximizing efficiency and quality for the patients and physicians they serve.

Download the transcript of this eCase study video. 

Sponsored by
Case Study
In this on-demand video presentation, Dr. Keith Gligorich, laboratory operations director at Navican Precision Cancer Care, discusses his experiences implementing a next-generation sequencing quality management system at Navican. 
Download the video to hear Dr. Gligorich explain the details of Navican's NGS quality management system and how it addresses the complexities of the precision medicine workflow.  
Sponsored by

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.